RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: parasitic helminthiasis infectious disease
Accession: DOID:883
browse the term
Definition: A parasitic infectious disease that occurs when part of the body is infested with parasitic worms such as cestodes, nematodes and trematodes. (DO)
Synonyms: exact_synonym: helminth infection; helminthiases; helminthiasis; helminthosis; nematomorpha infection; nematomorpha infections; worm infection
primary_id: MESH:D006373
xref: EFO:1001342 ; ICD10CM:B83.9 ; ICD9CM:120-129.99 ; NCI:C84751
For additional species annotation, visit the
Alliance of Genome Resources .
G
Il2rb
interleukin 2 receptor subunit beta
ameliorates
ISO
RGD
PMID:21301182
RGD:42724469
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il33
interleukin 33
treatment
ISO
RGD
PMID:25912172
RGD:39939026
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Mir146a
microRNA 146a
exacerbates
ISO
RGD
PMID:25024218
RGD:126925154
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Cd274
CD274 molecule
treatment
ISO
RGD
PMID:30315719
RGD:41410787
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
RT1-Bb
RT1 class II, locus Bb
disease_progression
ISO
DNA:polymorphism: :HLA-DQB1*02(human)
RGD
PMID:9756400
RGD:36174003
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphisms: :HLA-DRB1*03, DRB1*11(human)
RGD
PMID:9756400
RGD:36174003
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:PBMC
RGD
PMID:30141853
RGD:15090814
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Il1rl1
interleukin 1 receptor-like 1
treatment
ISO
mRNA:increased expression:brain:
RGD
PMID:24657070 PMID:23148283
RGD:11561855 , RGD:40400713
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il33
interleukin 33
ISO
protein:increased expression:brain:
RGD
PMID:23148283 PMID:24076431
RGD:40400713 , RGD:40400715
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il5
interleukin 5
ISO
RGD
PMID:8361777
RGD:11354948
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Mag
myelin-associated glycoprotein
disease_progression
ISO
RGD
PMID:20399564
RGD:27226693
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
G
Mbp
myelin basic protein
disease_progression
ISO
RGD
PMID:20399564
RGD:27226693
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mobp
myelin-associated oligodendrocyte basic protein
disease_progression
ISO
RGD
PMID:20399564
RGD:27226693
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
G
Cd40
CD40 molecule
ISO
protein:increased expression:plasmacytoid dendritic cell
RGD
PMID:20702728
RGD:5490530
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
RGD
PMID:17187651
RGD:7349350
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Fas
Fas cell surface death receptor
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18427836
RGD:2315733
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
IEP
mRNA, protein:increased expression:liver
RGD
PMID:18427836
RGD:2315733
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Il33
interleukin 33
ISO
mRNA,protein:increased expression:liver, serum: protein:increased expression:serum:
RGD
PMID:26944417 PMID:26944417
RGD:39939001 , RGD:39939001
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:28784165
RGD:15090810
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:25726962
RGD:14696685
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphisms: :HLA- DQB1*0.9, DQB1*02(human)
RGD
PMID:22308705
RGD:36174019
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphism: :HLA-DRB1*03, DRB1*07(human)
RGD
PMID:22308705
RGD:36174019
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Tlr2
toll-like receptor 2
disease_progression
ISO
DNA:mutation:cds:Arg753Gln(human) mRNA:increased expression:peripheral blood monocyte:
RGD
PMID:31437685 PMID:21923667
RGD:15090825 , RGD:18182935
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:peripheral blood monocyte:
RGD
PMID:21923667
RGD:18182935
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
RGD
PMID:2142987
RGD:5128834
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24270252
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Hbb
hemoglobin subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24270252
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Il5
interleukin 5
ISO
mRNA: increased expression: : peritoneal lavage cells
RGD
PMID:21912714
RGD:5687176
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24270252
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Ctsb
cathepsin B
IEP
protein:decreased activity:liver (rat)
RGD
PMID:19696938
RGD:2315504
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Glud1
glutamate dehydrogenase 1
IEP
protein:increased expression:serum
RGD
PMID:10431747
RGD:6484593
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Il1rl1
interleukin 1 receptor-like 1
ISO
RGD
PMID:27592711
RGD:40400889
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
ISO
RGD
PMID:24626328
RGD:40903014
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
G
Cd274
CD274 molecule
ISO
mRNA, protein:increased expression:liver
RGD
PMID:25907244
RGD:41412175
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:serum
RGD
PMID:12927688
RGD:5509967
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Pdcd1
programmed cell death 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:25907244
RGD:41412175
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Cd209a
CD209a molecule
ISO
mRNA,protein:decreased expression:spleen,liver (mouse)
RGD
PMID:29386115 PMID:24729611
RGD:39938990 , RGD:39938995
NCBI chr12:1,822,663...1,828,246
Ensembl chr12:1,822,663...1,828,246
G
Clec4m
C-type lectin domain family 4 member M
ISO
RGD
PMID:18981244
RGD:39938988
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
G
Krt18
keratin 18
disease_progression
ISO
protein:increased expression:serum (mouse, human)
RGD
PMID:21357724
RGD:21406434
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:liver, hepatic stellate cell (mouse) miRNA:increased expression:liver (mouse) miRNA:increased expression:liver, macrophage (mouse)
RGD
PMID:25116007 PMID:25051829 PMID:27780686
RGD:126925174 , RGD:126925180 , RGD:126925179
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Serpinf1
serpin family F member 1
ISO
RGD
PMID:9038736
RGD:30296660
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Il1rl1
interleukin 1 receptor-like 1
ISO
RGD
PMID:22329990
RGD:39938827
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il33
interleukin 33
ISO
mRNA,protein:increased expression:Bronchoalveolar lavage, epithelium, macrophage
RGD
PMID:22329990
RGD:39938827
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Tff2
trefoil factor 2
ISO
RGD
PMID:22329990
RGD:39938827
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
G
Ifng
interferon gamma
ISO
RGD
PMID:29950724
RGD:14974257
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Nfkb1
nuclear factor kappa B subunit 1
disease_progression
ISO
RGD
PMID:12370384
RGD:40902988
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
treatment
ISO
RGD
PMID:12370384
RGD:40902988
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
protein:increased expression:liver (rat)
RGD
PMID:12621079
RGD:2306675
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Il1rl1
interleukin 1 receptor-like 1
severity
ISO
RGD
PMID:27697499
RGD:40400689
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il33
interleukin 33
ISO
associated with Nippostrongylus brasiliensis infection; mRNA:increased expression:lung
RGD
PMID:22331917
RGD:40400742
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
IEP
mRNA:increased expression:spleen
RGD
PMID:17570971
RGD:2317296
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Muc13
mucin 13, cell surface associated
ISO
protein:increased expression:cecum, glycocalyx
RGD
PMID:21155842
RGD:7364766
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP ISO
mRNA:increased expression:intestine
RGD
PMID:16689826 PMID:20138044
RGD:2303607 , RGD:7349349
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Muc3
mucin 3
IEP
mRNA:increased expression:intestine
RGD
PMID:16689826
RGD:2303607
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
G
Muc4
mucin 4, cell surface associated
IEP ISO
mRNA:increased expression:intestine protein:increased expression:cecum, glycocalyx
RGD
PMID:16689826 PMID:21155842
RGD:2303607 , RGD:7364766
NCBI chr11:68,008,245...68,053,242
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
resistance
ISO IEP
mRNA:increased expression:cecum
RGD
PMID:20138044 PMID:22269441
RGD:7349349 , RGD:7364747
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
susceptibility
ISO
RGD
PMID:11850627
RGD:737789
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:20695884
RGD:5130965
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Il1r1
interleukin 1 receptor type 1
ISO
RGD
PMID:19168746
RGD:8662882
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:11884755
RGD:7794682
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Il13
interleukin 13
severity
ISO
protein:increased expression:serum
RGD
PMID:22805723
RGD:8549600
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms: :HLA-DQA1*0401, HLA-DQA1*0102,HLA-DQA1*0103;
RGD
PMID:22117902
RGD:8547660
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Ha
RT1 class II, locus Ha
ISO
RGD
PMID:8854084
RGD:6480649
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Actr3
actin related protein 3
ISO
RGD
PMID:25809205
RGD:11570559
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
G
Mir192
microRNA 192
ISO
RNA:increased expression:urine
RGD
PMID:26456596
RGD:41404678
NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055
G
Ager
advanced glycosylation end product-specific receptor
ISO
protein:decreased expression:lung (mouse)
RGD
PMID:23369670
RGD:7243187
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Bud31
BUD31 homolog
IEP
Protein:increased expression:serum (human)
RGD
PMID:22686541
RGD:10058982
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
G
Il33
interleukin 33
ISO
mRNA,protein:increased expression:liver
RGD
PMID:29554131
RGD:39938854
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Mir146a
microRNA 146a
disease_progression
ISO
miRNA:altered expression: blood serum (mouse)
RGD
PMID:32443549
RGD:126925171
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19041905
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Rassf1
Ras association domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23527093
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
RT1-Db1
RT1 class II, locus Db1
treatment
ISO
DNA:polymorphism: :HLA-DRB1*13
RGD
PMID:16709874
RGD:36049813
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Sting1
stimulator of interferon response cGAMP interactor 1
ISO
RGD
PMID:32404867
RGD:39128195
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
G
Timp3
TIMP metallopeptidase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23527093
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Cd1d1
CD1d1 molecule
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il33
interleukin 33
treatment severity
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738 PMID:25944738
RGD:39939027 , RGD:40400890 , RGD:40400890
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Mir223
microRNA 223
treatment
ISO
RNA:increased expression:plasma:
RGD
PMID:24330517 PMID:24330517
RGD:21408589 , RGD:21408589
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733 PMID:27792733 PMID:27792733
RGD:40818413 , RGD:40818413 , RGD:40818413
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16042197
RGD:14398841
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
Serpinh1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Ihh
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
G
Il13
interleukin 13
treatment
IMP
RGD
PMID:10903803
RGD:8549615
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Tlr9
toll-like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Trem1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Aicda
activation-induced cytidine deaminase
ISO
RGD
PMID:23630966
RGD:32716404
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
G
Il3
interleukin 3
ISO
RGD
PMID:20500666
RGD:5686890
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il33
interleukin 33
ISO
mRNA:increased expression:lung
RGD
PMID:22331917
RGD:40400742
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Plau
plasminogen activator, urokinase
IMP
RGD
PMID:18022622
RGD:6484141
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:16129701
RGD:8655932
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il5
interleukin 5
severity
ISO
RGD
PMID:9824515
RGD:11354934
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Tslp
thymic stromal lymphopoietin
ISO
mRNA:increased expression:multiple (mouse)
RGD
PMID:24327787
RGD:38596353
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Ccl11
C-C motif chemokine ligand 11
ISO
protein:increased expression:plasma, respiratory system fluid/secretion
RGD
PMID:16168564
RGD:7248410
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:26732352
RGD:11534298
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Olig2
oligodendrocyte transcription factor 2
ISO
RGD
PMID:25773181
RGD:40902825
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
G
Il10
interleukin 10
ISO
RGD
PMID:23465441
RGD:11049476
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Lta
lymphotoxin alpha
ISO
RGD
PMID:19564380
RGD:8548805
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Slc17a8
solute carrier family 17 member 8
IEP
protein:increased expression:dorsal horn of spinal cord, dorsal root ganglion
RGD
PMID:22160634
RGD:9999169
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
G
Slc6a4
solute carrier family 6 member 4
ISO
protein:decreased expression:jejunum (mouse)
RGD
PMID:16336502
RGD:38676482
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19564380
RGD:8548805
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tslp
thymic stromal lymphopoietin
disease_progression
ISO
RGD
PMID:23024277
RGD:38596337
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Foxp1
forkhead box P1
IEP
mRNA:increased expression:duodenum (rat)
RGD
PMID:21698235
RGD:11561920
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864659
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864659
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Tslp
thymic stromal lymphopoietin
susceptibility
ISO
RGD
PMID:19273626
RGD:38549593
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Cd1d1
CD1d1 molecule
ISO
protein:increased expression:B cell (human)
RGD
PMID:22347409
RGD:127345101
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNPs:multiple:Gabonese(human)
RGD
PMID:22288822
RGD:7204674
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Il5
interleukin 5
resistance
ISO
RGD
PMID:9697734
RGD:7241010
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Stat6
signal transducer and activator of transcription 6
severity
ISO
DNA:SNP:enhancer: (rs324013)
RGD
PMID:18273035
RGD:7243977
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all